September 2025
1. NIERENGARTEN MB
   Neoadjuvant immunochemotherapy for nonsurgical HPV-negative head and neck cancer.
   Cancer. 2025;131:e70036.
   

   >> Share

   
   
2. NIERENGARTEN MB
   Report provides review of major modifiable cancer risk factors, HPV vaccination, and cancer screenings: Improving cancer prevention is critical to lowering the burden of cancer.
   Cancer. 2025;131:e70034.
   

   >> Share

   
   May 2025
3. KLOSKY JL, Cherven B, Gilkey MB, Aye J, et al
   A framework-based guide for adapting and implementing primary care-based pediatric interventions to the pediatric oncology setting: HPV PROTECT as an exemplar.
   Cancer. 2025;131:e35857.
   

   >> Share

   
   February 2025
4. NIERENGARTEN MB
   Men face substantial lifelong risk of oral HPV infection: A study provides information on rates of newly acquired oral HPV infections and associated risk factors for acquiring HPV infections in a multinational cohort of more than 3000 men.
   Cancer. 2025;131:e35714.
   

   >> Share

   
   March 2024
5. CONTRERA KJ, Patel MR, Burtness B, Mehra R, et al
   The role of surgery and deescalation for HPV-related oropharyngeal cancer.
   Cancer. 2024 Mar 18. doi: 10.1002/cncr.35287.
   

   >> Share

   
   December 2023
6. 
   Researchers identify two new subtypes of HPV-associated head and neck cancers.
   Cancer. 2023;129:3842.
   

   >> Share

   
   
7. NAZHA B, Zhuang T, Wu S, Brown JT, et al
   Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune-checkpoint inhibitor-related biomarkers.
   Cancer. 2023;129:3884-3893.
   

   >> Share

   
   November 2023
8. 
   HPV testing in older women may improve cervical cancer prevention.
   Cancer. 2023;129:3518.
   

   >> Share

   
   June 2023
9. FRANCO EL
   The time has come to implement primary human papillomavirus screening for cervical cancer in the United States.
   Cancer. 2023 Jun 22. doi: 10.1002/cncr.34899.
   

   >> Share

   
   May 2023
10. RAMKUMAR SP, Simpson MC, Adjei Boakye E, Bukatko AR, et al
    High-risk human papillomavirus 16/18 associated with improved survival in sinonasal squamous cell carcinoma.
    Cancer. 2023;129:1372-1383.
    

    >> Share

    
    April 2023
11. AREVALO M, Brownstein NC, Whiting J, Vadaparampil ST, et al
    Factors related to human papillomavirus vaccine uptake and intentions among adults aged 18-26 and 27-45 years in the United States: A cross-sectional study.
    Cancer. 2023;129:1237-1252.
    

    >> Share

    
    
12. D'SOUZA G, Tewari SR, Troy T, Waterboer T, et al
    Prevalence of oral and blood oncogenic human papillomavirus biomarkers among an enriched screening population: Baseline results of the MOUTH study.
    Cancer. 2023 Apr 9. doi: 10.1002/cncr.34783.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share